Genmab
GMAB
GMAB
225 hedge funds and large institutions have $1.51B invested in Genmab in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 54 increasing their positions, 103 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $1.67B → $1.51B (-$162M)
48% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 103
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
225
Holding in Top 10
1
Calls
$996K
Puts
$178K
Top Buyers
| 1 | +$194M | |
| 2 | +$34.3M | |
| 3 | +$11.8M | |
| 4 |
Renaissance Technologies
New York
|
+$10.2M |
| 5 |
AP
Antipodes Partners
Royal Exchange,
Australia
|
+$5.91M |
Top Sellers
| 1 | -$103M | |
| 2 | -$79.1M | |
| 3 | -$16.8M | |
| 4 |
BlackRock
New York
|
-$13M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$8.32M |